New Addition to GoIncubation Board: HomeRun Biotech to List on December 29th
2025.12.26
NewsWritten by: News Center | Global Bio and Investment Monthly
Date: December 24, 2025
Today (24th), the Taipei Exchange (TPEx) announced a new addition to the biotech and pharmaceutical sector of the GoIncubation Board. HomeRun Biotech (Stock Code: 7695) is scheduled to officially list on the GoIncubation Board on December 29th.
HomeRun Biotech is dedicated to the biotechnology and healthcare industries. Through industry-academic collaborations, the company develops premium health supplements and beauty skincare products. Its foundation rests on three core technologies: "Ginkgo-Cultivated Cordyceps Militaris," "Plant-based Active Polysaccharides," and "Natural Plant Enzymes," with a primary focus on the advancement of preventive medicine.
Adhering to its founding principles of "Natural, Safe, Vegan, and Eco-friendly," HomeRun Biotech has actively invested in the R&D of " Ginkgo-Cultivated Cordyceps Militaris" and various other cordyceps cultivated from natural plants. These efforts have secured numerous invention patents and international gold awards. The company has demonstrated extensive application value and potential in the fields of health supplements and adjuvant therapy. Furthermore, it collaborates with multiple hospitals on clinical data to develop precision nutrition products, aiming to provide more maintenance and recovery options for patients with chronic diseases and cancer.
"Integrative Oncology" and "Regenerative Medicine" are key global directions in medical research. After more than a decade of research and development, HomeRun Biotech has established industry-academic partnerships with institutions such as Hualien Tzu Chi Medical Center and the National Defense Medical University. The company is committed to innovative research and the development of new botanical drugs using "Cordyceps" in the fields of integrative oncology and orthopedic regenerative medicine.
(Note: This news is a general release from the Taipei Exchange for reference only. For actual progress, please refer to official material information announcements, internal financial reports, and business information released by the company.)
-----------------------------------
相關媒體報導連結:
《櫃買市場》宏潤生物、紐因科技29日登錄創櫃板 | 中時新聞網